Atlas Trials

Circulating Tumor DNA Based Minimal Residual Disease Detection for Patients With Early-Stage Breast Cancer

Clinical trial NCT07136493 · WITHDRAWN

Trial details

NCT number
NCT07136493
Sponsor
City of Hope Medical Center
Status
WITHDRAWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Estrogen Receptor-Positive Breast CarcinomaHER2-Negative Breast CarcinomaHER2-Positive Breast CarcinomaTriple-Negative Breast Carcinoma
Start date
2026-05-12
Primary completion
2026-06-16
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.